Copenhagen Affective Disorder Research Centre (CADIC), Psychiatric Centre Copenhagen, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Deparment of Psychology, University of Copenhagen, Copenhagen, Denmark.
Bipolar Disord. 2018 May;20(3):184-194. doi: 10.1111/bdi.12595. Epub 2018 Jan 18.
Cognition is a new treatment target to aid functional recovery and enhance quality of life for patients with bipolar disorder. The International Society for Bipolar Disorders (ISBD) Targeting Cognition Task Force aimed to develop consensus-based clinical recommendations on whether, when and how to assess and address cognitive impairment.
The task force, consisting of 19 international experts from nine countries, discussed the challenges and recommendations in a face-to-face meeting, telephone conference call and email exchanges. Consensus-based recommendations were achieved through these exchanges with no need for formal consensus methods.
The identified questions were: (I) Should cognitive screening assessments be routinely conducted in clinical settings? (II) What are the most feasible screening tools? (III) What are the implications if cognitive impairment is detected? (IV) What are the treatment perspectives? Key recommendations are that clinicians: (I) formally screen cognition in partially or fully remitted patients whenever possible, (II) use brief, easy-to-administer tools such as the Screen for Cognitive Impairment in Psychiatry and Cognitive Complaints in Bipolar Disorder Rating Assessment, and (III) evaluate the impact of medication and comorbidity, refer patients for comprehensive neuropsychological evaluation when clinically indicated, and encourage patients to build cognitive reserve. Regarding question (IV), there is limited evidence for current evidence-based treatments but intense research efforts are underway to identify new pharmacological and/or psychological cognition treatments.
This task force paper provides the first consensus-based recommendations for clinicians on whether, when, and how to assess and address cognition, which may aid patients' functional recovery and improve their quality of life.
认知是一个新的治疗靶点,有助于双相情感障碍患者的功能恢复和提高生活质量。国际双相情感障碍学会(ISBD)认知目标工作组旨在就评估和治疗认知障碍的时机和方法达成基于共识的临床建议。
该工作组由来自九个国家的 19 名国际专家组成,通过面对面会议、电话会议和电子邮件交流讨论了面临的挑战和建议。通过这些交流达成了基于共识的建议,无需使用正式的共识方法。
确定的问题是:(一)是否应在临床环境中常规进行认知筛查评估?(二)最可行的筛查工具是什么?(三)如果发现认知障碍,其意味着什么?(四)治疗视角是什么?主要建议是,临床医生:(一)只要有可能,就应正式筛查部分或完全缓解患者的认知功能;(二)使用简短、易于管理的工具,如精神科认知障碍筛查和双相情感障碍认知抱怨评定量表;(三)评估药物和合并症的影响,当临床需要时,为患者提供全面的神经心理学评估,并鼓励患者建立认知储备。关于问题(四),目前针对基于证据的治疗方法的证据有限,但正在进行大量研究工作,以确定新的药理学和/或心理认知治疗方法。
本工作组文件为临床医生提供了关于是否、何时以及如何评估和治疗认知的第一个基于共识的建议,这可能有助于患者的功能恢复并提高他们的生活质量。